Targeting of drugs 4 : advances in system constructs
著者
書誌事項
Targeting of drugs 4 : advances in system constructs
(NATO ASI series, Ser. A . Life sciences ; v. 273)
Plenum Press, c1994
- タイトル別名
-
Targeting of drugs four
大学図書館所蔵 全7件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
"Proceedings of a NATO Advanced Study Institute on Targeting of Drugs: Advances in System Constructs, held June 24-July 5, 1993, in Cape Sounion, Greece"--T.p. verso
Published in cooperation with NATO Scientific Affairs Division
Includes bibliographical references and index
内容説明・目次
内容説明
The NATO Advanced Studies Institute series "Targeting of Drugs" was originated in 1981. It is now a major international forum, held every two years in Cape Sounion, Greece, in which the present and the future of this important area of research in drug delivery is discussed in great depth. Previous ASIs of the series dealt with drug carriers of natural and synthetic origin, their interaction with the biological milieu, ways by which the latter influences such interaction, strategies by which milieu interference curtailing the function of drug carriers is circumvented and, more recently, with the application of drug carriers for the delivery of peptides and proteins. The present book contains the of the 7th NATO ASI "Targeting of Drugs: Advances in System Constructs", proceedings held in Cape Sounion during 24 June -5 July 1993. As the title implies, the book deals with a variety of approaches to carrier design or modification that contribute to optimal carrier function. to Mrs Concha Perring for her assistance with the We express our appreciation organization of the ASI. We thank Dr. G. Deliconstantinos who, as chairperson of the Local Committee, contributed to the success of the Institute. The ASI was held under the sponsorship of NATO Scientific Affairs Division and co-sponsored and generously financed by SmithKline Beecham Pharmaceuticals (King of Prussia). Financial assistance was also provided by Liposome Technology Inc. (Menlo Park), Vestar Inc. (San Dimas) and Zeneka (Macclesfield).
目次
- Drug Targeting with Glycoproteins and other Peptide Carriers: An Overview
- D.K.F. Meijer. Sugar Specific Delivery of Drugs, Oligonucleotides, and Genes
- M. Monsigny, et al. The Use of MSH Derivatives for Targeting to Melanomas
- D.R. Bard, et al. The Immunogenicity of Recombinant Proteins and of 'Magic Bullets' Represents the Main Obstacle for the Effective in vivo Targeting of Biological Response Modifiers (BRMs)
- A.H. Sehon. Targeting of Drugs to Tumors: The Use of the Plasminogen Activator Inhibitor as a Ligand
- J. Jankun. Advances in Diagnosis and Treatment of Neoplasia Using Radioactive Monoclonal Antibodies
- A. Maraveyas, A.A. Epenetos. Targeting Transcription Factors to Inhibit Selectively Gene Expression in Particular Cell Types
- A.C. Allison, E.M. Eugui. Design, Biological Properties and Delivery of Antisense Oligonucleotides
- J.S. Cohen. Liposomes in vivo: Control of Behaviour
- G. Gregoriadis. Passive Targeting of Anthracyclines Entrapped in Longcirculating (Stealth) Liposomes in the Treatment of Cancer
- T.M. Allen. Liposomal Drug Delivery: Possibilities for Manipulation
- G. Storm, et al. 6 additional articles. Index.
「Nielsen BookData」 より